Amarin Corp Plc (AMRN)

[Whalatane]

No mo

I do not think the FDA can screw with the Reduce it trial for the reasons mention in my reply to Lad and the reasons put forth by STS and HDGator .
No all of us thought the Anchor Adcom was a slam dunk ...DR Nissen of the Cleveland clinic , Adam Fuerstein and others had warned that the FDA would be unlikely to approve a drug for such a large mixed D population based solely on changes on risk markers.....especially if the risk marker was not LDL cholesterol

I thought it was likely , but not certain , that they would approve simply on a risk / benefit basis .....and think they have made a huge mistake by not approving wider use .

Imagine RI is stopped for efficacy late 2015 ....then imagine the calculations on how many lives were lost because the FDA failed to approve the Anchor indication 2 yrs earlier.
If RI fails ...what's the damage . None that I can see expect for wasted $ on some very expensive fish oil .
Vascepa , without insurance , is costing me $5 a day

Kiwi